Palbociclib induces DNA damage and inhibits DNA repair to induce cellular senescence and apoptosis in oral squamous cell carcinoma

Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future

(2020) Laura M Spring et al.   LANCET

The Ongoing Search for Biomarkers of CDK4/6 Inhibitor Responsiveness in Breast Cancer

(2020) Scott F. Schoninger et al.   MOLECULAR CANCER THERAPEUTICS

Hydroxygenkwanin Suppresses Non-Small Cell Lung Cancer Progression by Enhancing EGFR Degradation

(2020) Yann-Lii Leu et al.   MOLECULES

Immune Checkpoint Inhibitors in Oral Cavity Squamous Cell Carcinoma and Oral Potentially Malignant Disorders: A Systematic Review

(2020) Omar Kujan et al.   Cancers

Head and neck cancer prevention: from primary prevention to impact of clinicians on reducing burden

(2019) Dana Hashim et al.   ANNALS OF ONCOLOGY

Combination of 5-Florouracil and polyphenol EGCG exerts suppressive effects on oral cancer cells exposed to radiation

(2019) Eduardo Pons-Fuster López et al.   ARCHIVES OF ORAL BIOLOGY

Targeted therapies for non-HPV-related head and neck cancer: challenges and opportunities in the context of predictive, preventive, and personalized medicine

(2019) Linah A. Shahoumi et al.   EPMA Journal

Induction chemotherapy in head and neck cancers: Results and controversies

(2019) Max Gau et al.   ORAL ONCOLOGY

p21 in Cancer Research

(2019) Shamloo et al.   Cancers

Multiple effects of CDK4/6 inhibition in cancer: From cell cycle arrest to immunomodulation

(2019) Mara Bonelli et al.   BIOCHEMICAL PHARMACOLOGY

Immunotherapy for head and neck cancer: Recent advances and future directions

(2019) John D. Cramer et al.   ORAL ONCOLOGY

Oral Cancer

(2019) Chia-Cheng Li et al.   Surgical Oncology Clinics of North America

Multicenter retrospective study of cetuximab plus platinum-based chemotherapy for recurrent or metastatic oral squamous cell carcinoma

(2018) Souichi Yanamoto et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and stabilization of p14ARF

(2018) Aram Ko et al.   CELL DEATH AND DIFFERENTIATION

Corylin Suppresses Hepatocellular Carcinoma Progression via the Inhibition of Epithelial-Mesenchymal Transition, Mediated by Long Noncoding RNA GAS5

(2018) Chi-Yuan Chen et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Nanomedicine, an emerging therapeutic strategy for oral cancer therapy

(2018) Sabrina Marcazzan et al.   ORAL ONCOLOGY

Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review

(2018) Kamal Pandey et al.   INTERNATIONAL JOURNAL OF CANCER

CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors

(2018) Francesco Schettini et al.   Frontiers in Oncology

Novel focal adhesion kinase 1 inhibitor sensitizes lung cancer cells to radiation in a p53-independent manner

(2017) Seung-Youn Jung et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Induction of p53-Independent Apoptosis and G1 Cell Cycle Arrest by Fucoidan in HCT116 Human Colorectal Carcinoma Cells

(2017) Hye Park et al.   Marine Drugs

Amplification of EGFR and cyclin D1 genes associated with human papillomavirus infection in oral squamous cell carcinoma

(2017) Jureeporn Chuerduangphui et al.   MEDICAL ONCOLOGY

The EGFR Inhibitor Gefitinib Enhanced the Response of Human Oral Squamous Cell Carcinoma to Cisplatin In Vitro

(2017) Ashraf Khalil et al.   Drugs in research & development

MYC—Master Regulator of the Cancer Epigenome and Transcriptome

(2017) Candace J. Poole et al.   Genes

Dynamics of ARF regulation that control senescence and cancer

(2016) Aram Ko et al.   BMB Reports

Roles of FGFR in oral carcinogenesis

(2016) Xiaoyan Xie et al.   CELL PROLIFERATION

Overcoming radioresistance in head and neck squamous cell carcinoma

(2016) Vicky N. Yamamoto et al.   ORAL ONCOLOGY

Palbociclib (PD0332991)—a Selective and Potent Cyclin-Dependent Kinase Inhibitor

(2016) Amy S. Clark et al.   JAMA Oncology

Palbociclib for the Treatment of Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer

(2015) A. Morikawa et al.   CLINICAL CANCER RESEARCH

The Role of CDK4/6 Inhibition in Breast Cancer

(2015) C. G. Murphy et al.   ONCOLOGIST

Loss of epidermal growth factor receptor expression in oral squamous cell carcinoma is associated with invasiveness and epithelial-mesenchymal transition

(2015) IYO KIMURA et al.   Oncology Letters

p19ARF is a critical mediator of both cellular senescence and an innate immune response associated with MYC inactivation in mouse model of acute leukemia

(2015) Alper Yetil et al.   Oncotarget

Current challenges and clinical investigations of epidermal growth factor receptor (EGFR)- and ErbB family-targeted agents in the treatment of head and neck squamous cell carcinoma (HNSCC)

(2013) Roger B. Cohen   CANCER TREATMENT REVIEWS

The recurrence and survival of oral squamous cell carcinoma: a report of 275 cases

(2013) Bo Wang et al.   Chinese Journal of Cancer

Myc, Cdk2 and cellular senescence: Old players, new game

(2010) Stefano Campaner et al.   CELL CYCLE

Epidermal growth factor receptor targeted therapy in stage III and IV head and neck cancer

(2010) C. Cripps et al.   Current Oncology

Oral cancer: Clinical features

(2010) Jose Bagan et al.   ORAL ONCOLOGY

Tid1 functions as a tumour suppressor in head and neck squamous cell carcinoma

(2009) Chi-Yuan Chen et al.   JOURNAL OF PATHOLOGY

Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation

(2009) P. Hydbring et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA